4.8 Article

Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Liver transcript analysis reveals aberrant splicing due to silent and intronic variations in the ABCB11 gene

Anne Davit-Spraul et al.

MOLECULAR GENETICS AND METABOLISM (2014)

Article Genetics & Heredity

Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1

Yasuhiro Hasegawa et al.

ORPHANET JOURNAL OF RARE DISEASES (2014)

Article Gastroenterology & Hepatology

Folding Defects in P-Type ATP 8B1 Associated with Hereditary Cholestasis Are Ameliorated by 4-Phenylbutyrate

Lieke M. van der Velden et al.

HEPATOLOGY (2010)

Review Gastroenterology & Hepatology

Liver disease associated with canalicular transport defects: Current and future therapies

Janneke M. Stapelbroek et al.

JOURNAL OF HEPATOLOGY (2010)

Article Gastroenterology & Hepatology

Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells

Tatehiro Kagawa et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)

Article Gastroenterology & Hepatology

Severe bile salt export pump deficiency:: 82 different ABCB11 mutations in 109 families

Sandra S. Strautnieks et al.

GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

Effect of ursodeoxycholic acid on the expression of the hepatocellular bile acid transporters (Ntcp and bsep) in rats with estrogen-induced cholestasis

D Micheline et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)

Article Endocrinology & Metabolism

Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients

AB Burlina et al.

MOLECULAR GENETICS AND METABOLISM (2001)